Dolofen Plus

Quick links to important sections

Dolofen Plus

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dolofen Plus

Property Description
Active Ingredients Diclofenac and Paracetamol (Acetaminophen)
Form Oral Tablet
Pharmacological Class NSAID and Analgesic/Antipyretic
Common Use Relief of pain and associated inflammation
Origin Synthetic (Chemically manufactured)

What Type of Medicine is Dolofen Plus?

Dolofen Plus is a synthetic combination medicine that acts as both a pain reliever and an anti-inflammatory agent. It is categorized within two established pharmacological classes: a Non-Steroidal Anti-Inflammatory Drug (NSAID) and an Analgesic/Antipyretic (pain and fever reducer). This formulation combines two distinct mechanisms of action to provide symptomatic relief. It is a formulation used for addressing pain that involves an inflammatory component.

Active Ingredients and Dosage Form

The medicine is composed of two primary active ingredients (INN): Diclofenac and Paracetamol (also known as Acetaminophen). As a synthetic, fixed-dose combination, it is manufactured to ensure consistent quality and standardized delivery of both ingredients. Dolofen Plus is typically available as an oral tablet, meaning it is designed to be swallowed for oral administration, allowing its components to be absorbed systemically throughout the body. The combined use of these two agents offers a therapeutic advantage over either agent used alone.

What is the General Purpose of Dolofen Plus?

The general purpose of taking Dolofen Plus is to provide dual-action relief for moderate pain, especially in situations where inflammation is a primary contributing factor, such as musculoskeletal discomfort. The drug is designed to achieve this by simultaneously targeting the substances that cause swelling and pain signals, while also raising the body's tolerance to the feeling of pain. This advantage positions Dolofen Plus as an option for comprehensive pain and inflammation management.

What side effects are possible with Dolofen Plus?

Possible Side Effects and Safety Information

The official safety profile for medicines containing the components of Dolofen Plus (typically an NSAID combined with paracetamol/acetaminophen) highlights potential risks categorized by the body system affected and the likelihood of occurrence, as documented by government regulatory agencies.

Adverse Reaction Classification

Adverse reactions are formally classified by System-Organ Classes and Frequency based on clinical trials and surveillance data. Major systems involved include the Gastrointestinal Tract, Cardiovascular System, Renal and Urinary System, Hepatobiliary System, and Immune System.

Classification Examples of Reactions (Based on Regulatory Frequency Bands)
Common Indigestion, nausea, diarrhea, stomach pain.
Serious/Rare Gastrointestinal bleeding, perforation, severe allergic reactions, liver dysfunction.

Serious and Population-Specific Safety Considerations

Official safety documentation emphasizes specific, life-threatening risks:

  • Serious Adverse Reactions: These include potentially fatal events such as Gastrointestinal bleeding and ulceration, as well as major Arterial Thrombotic Events (e.g., myocardial infarction and stroke), particularly associated with the NSAID component.
  • Dose- and Exposure-Related Risks: Regulatory sources state that the risk of cardiovascular and serious gastrointestinal events increases with higher doses and longer duration of treatment. The lowest effective dose must be used for the shortest possible duration.
  • Population Restrictions: The medicine is contraindicated in specific patient groups, including those with established congestive heart failure (NYHA class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease. Caution is required in the elderly and those with pre-existing risk factors (e.g., hypertension, kidney impairment).

This structure ensures risks are communicated based on their type, likelihood, and relationship to patient-specific conditions and duration of use, guiding the understanding of the medicine’s official risk profile.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of this combination medicine involves two distinct, severe toxicity domains: acute hepatotoxicity from the Paracetamol component and systemic damage (Gastrointestinal and Cardiovascular) from the Diclofenac component. Officially documented manifestations of overdose can include initial symptoms such as Nausea, Vomiting, Abdominal Pain, and Diarrhea. These may progress to serious clinical signs, including Jaundice, Confusion, Drowsiness, Headache, Dizziness, and signs of internal bleeding such as bloody or black stools. Severe outcomes documented in regulatory sources include Acute Liver Failure, Gastrointestinal Perforation, and potentially fatal Cardiovascular Thrombotic Events.


Mandatory Emergency Action

Government regulatory guidance requires that individuals seek immediate medical attention or contact Poison Help right away if an overdose is suspected, even if no symptoms are apparent. This urgent action is mandated due to the delayed, potentially fatal nature of acute liver failure. The antidote for the Paracetamol component is N-acetylcysteine (NAC), and its administration is time-critical. For both active ingredients, treatment is generally symptomatic and supportive. Regulatory documents mandate intensive hospital monitoring, including frequent laboratory testing of hepatic (e.g., AST, ALT, INR) and renal function to manage and assess the extent of toxicity. Overdose risk carries more serious consequences in the elderly.

Therapeutic Uses of Dolofen Plus

The primary role of Dolofen Plus is to provide symptomatic relief for conditions presenting with systemic or localized discomfort characterized by the combination of pain and inflammation. The combination is generally considered relevant for managing symptom clusters that require additional supportive action. Such formulations are commonly used across multiple domains involving heightened symptoms.


This medication is generally used to help address symptoms related to physical discomfort in conditions like Osteoarthritis, Rheumatoid Arthritis flare-ups, and Ankylosing Spondylitis. It may be applied when appropriate for managing acute pain and swelling from sprains, strains, and lower backache. It also assists with managing generalized discomfort and elevated body temperature (fever), and is commonly used for recurrent pain such as tension headaches and painful menstrual cramping (dysmenorrhea). The medication helps maintain a sense of stability and contributes to easing the overall symptom load during periods of functional strain.

Therapeutic Focus Summary

Therapeutic Focus Summary
Addresses Symptoms: Physical discomfort, tenderness, stiffness, and localized swelling.
Core Benefit: Contributes to improved comfort during symptomatic periods.
Relevant Contexts: Applied in clinical settings that involve acute or unstable symptom patterns.

Regulatory References

  1. Ethiopian Food and Drug Authority (EFDA) guidance

Eligibility and Restrictions for Use

Dolofen Plus contains a non-steroidal anti-inflammatory drug (NSAID) component, such as diclofenac, and its official eligibility is strictly determined by governmental regulatory sources.

Populations for whom use is Contraindicated

The medicine must not be used by individuals with the following official restrictions:

  • A known allergy or severe hypersensitivity reaction (e.g., asthma, hives, or anaphylaxis) to the medicine, its ingredients, or to aspirin or other NSAIDs.
  • In the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • During the late stages of pregnancy (from about 30 weeks gestation and later).
  • Severe, established heart failure (NYHA Class II–IV, per some EU labeling).
  • Severe liver or kidney impairment.

Restricted or Not Recommended Use

Use is not recommended or requires special consideration in certain patient groups:

  • Children and Adolescents: Use is generally not established or suitable for children under 18 years of age.
  • Elderly Patients: Use with caution due to an increased risk of serious gastrointestinal or renal effects.
  • Pregnancy: Use is generally avoided from about 20 weeks gestation onward due to risk to the fetus (kidney problems and potential heart vessel closure).
  • Advanced Conditions: Patients with established ischemic heart disease, peripheral arterial disease, cerebrovascular disease, or a recent heart attack.

Eligibility is limited to adults who do not possess these documented clinical restrictions.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Dolofen Plus, which contains both Diclofenac and Paracetamol, has documented interactions that require careful consideration.


Contraindicated and High-Risk Combinations

Co-administration must be avoided with other NSAIDs (including COX-2 inhibitors) and high-dose Aspirin due to a significantly increased risk of serious gastrointestinal adverse effects. Combining Dolofen Plus with any other product containing Paracetamol/Acetaminophen is also strictly contraindicated to prevent exceeding the maximum daily dose and risking severe liver damage.

Clinically Significant Pharmacological Interactions

Interacting Drug/Class Documented Effect / Interaction Type
Anticoagulants (e.g., Warfarin) Increased risk of serious bleeding events due to additive effects.
Antihypertensives (e.g., ACE Inhibitors) Reduced effectiveness of the antihypertensive medication; increased risk of renal toxicity.
Lithium, Methotrexate Increased plasma concentrations of these drugs, necessitating close monitoring.
Alcohol Avoid use; chronic consumption significantly increases the risk of liver damage due to the Paracetamol component.
CYP2C9 Inhibitors/Inducers Altered blood levels of the Diclofenac component (e.g., inhibitors raise levels, inducers lower levels).

Monitoring and Procedural Requirements

Patients on Anticoagulants require mandatory increased monitoring of coagulation status (e.g., INR). Due to altered drug clearance, patients taking Lithium or Methotrexate must undergo therapeutic drug monitoring to prevent toxicity. The elderly and those with existing renal issues face an enhanced risk of renal function deterioration when co-administered with certain diuretics or antihypertensives.

Mechanism of Action

How Dolofen Plus Works

The pharmacodynamic mechanism of this combination involves a dual-action strategy: modulation of peripheral signaling cascades and modulation of central nociceptive pathways.


Peripheral Suppression of Pro-Inflammatory Mediators

This domain covers the action of Diclofenac, which functions primarily as an inhibitor of the Cyclooxygenase-2 (COX-2) enzyme at sites of tissue stress. By blocking COX-2, the drug limits the conversion of arachidonic acid into pro-inflammatory prostaglandins, which are chemical messengers responsible for modulating peripheral nociceptor thresholds. This mechanism results in the suppression of nociceptive signal generation and a reduction in local edema formation.


Central Modulation of Nociceptive Transmission

The second domain involves Paracetamol, which primarily acts within the Central Nervous System (CNS) to modulate the central transmission of nociceptive impulses in the brain and spinal cord. Its mechanism involves inhibiting central prostaglandin synthesis and indirectly modulating central pathways via a metabolite that interacts with receptors like TRPV1 and CB1. This molecular activity elevates the central nociceptive threshold, resulting in the attenuation of afferent impulse transmission across the CNS.


Mechanistic Complementarity via Multimodal Targeting

The combined formulation operates through complementary multimodal target engagement involving both peripheral and central domains. Diclofenac modulates the nociceptive signal originating from the periphery, while Paracetamol regulates the central response to afferent impulses. This parallel action engages two distinct, successive points in the overall pathway, resulting in multilevel physiological modulation.

Dosage and Administration Information

How Dolofen Plus is Used

Dolofen Plus is a fixed-dose combination medication containing Diclofenac and Paracetamol (Acetaminophen) that is designed for oral administration as a tablet. The administration guidelines are structured around maximizing benefit while strictly controlling exposure to both components.


Standard Dosing and Frequency

A standard adult dosing schedule involves one tablet (50 mg Diclofenac / 500 mg Paracetamol) to be taken two to three times a day. The total daily intake is divided into separate doses. Under no circumstances should the total daily dose exceed three tablets in a 24-hour period, which corresponds to a maximum of 150 mg of Diclofenac and 1500 mg of Paracetamol.

The overarching principle for use is to employ the lowest effective dose for the shortest duration necessary for symptomatic management.


Administration Requirements

Administration Aspect Requirement
Ingestion Method Tablets are to be swallowed whole with liquid; they are not to be crushed, broken, or chewed.
Timing Relative to Food The tablet is typically directed to be taken with or immediately after meals.

Population-Specific Adjustments

Dosage modifications are applied for specific populations. A reduced dosage is used for older adults (the elderly). Furthermore, for patients with hepatic (liver) impairment, a dose reduction is required, and the total Paracetamol intake from all sources must not exceed 2 g daily. These instructions define the use pattern based on the patient's physiological status.

Recent Clinical Evidence

Dolofen Plus is a fixed-dose combination analgesic containing tramadol (an opioid) and acetaminophen (paracetamol). It is indicated for the symptomatic treatment of moderate to moderately severe pain.

Efficacy in Acute and Chronic Pain

Clinical trials have demonstrated that the combination of tramadol and acetaminophen offers superior pain relief compared to placebo or either component used alone for the short-term management of acute pain, such as postoperative dental pain and other minor surgeries. This synergistic action allows for effective analgesia while potentially using lower doses of each drug.

In studies focusing on chronic pain conditions, particularly osteoarthritis and chronic low back pain, the combination has shown efficacy in reducing pain intensity and improving functional outcomes when compared to placebo. However, a major review of evidence suggested that the overall clinical benefit for pain and function in osteoarthritis patients may be small and not clinically significant, and there is an ongoing need for high-quality, long-term studies to better position the treatment.

Safety and Tolerability Profile

Key clinical research highlights that the fixed-dose combination generally exhibits a safety profile similar to that of tramadol monotherapy. Adverse events are more frequently reported with the combination drug than with placebo or acetaminophen alone. The most common side effects reported in clinical trials include:

Adverse Event Category Common Examples
Gastrointestinal Nausea, Vomiting, Constipation
Nervous System Dizziness, Somnolence (Drowsiness)

It is important to note that the risks associated with the opioid component, such as dependence and respiratory depression, remain crucial considerations, particularly with long-term use. Additionally, the maximum daily dose of the combination must be carefully monitored to avoid the risk of acetaminophen-related liver toxicity.

Frequently Asked Questions (FAQ)

Common questions about Dolofen Plus (FAQ)

Q: How long does it typically take for Dolofen Plus to start working?

Official product information suggests that the Paracetamol component of the medicine is quickly absorbed into the body, typically reaching measurable concentrations in the blood within 20 to 30 minutes after ingestion. This rapid absorption may be associated with a quicker onset of pain relief.


Q: How long do the effects of Dolofen Plus usually last?

The effects of the medicine are related to the time it takes for the active ingredients to be processed by the body. The half-life of the main component, Diclofenac, is approximately two hours. This duration of action is consistent with how the medicine is typically prescribed.


Q: Is it common to feel drowsy after taking Dolofen Plus?

Regulatory documents list central nervous system disturbances as potential side effects. These may include feelings of dizziness or drowsiness (somnolence). While not everyone experiences them, these effects are officially recognized possibilities.


Q: Can Dolofen Plus cause stomach upset or digestive issues?

Yes, common adverse effects documented in official safety information include gastrointestinal disorders. These may present as nausea, vomiting, diarrhea, stomach pain, or heartburn. Product labels indicate that taking the tablets with food is often recommended.


Q: Can Dolofen Plus be used for chronic conditions, or is it only for acute pain?

Official information indicates the medicine is used to manage pain and inflammation associated with certain chronic conditions, such as forms of arthritis. However, the regulatory guidance emphasizes using the lowest effective dose for the shortest duration necessary.


Q: Is it safe to take Dolofen Plus on an empty stomach?

The regulatory documents for Dolofen Plus typically direct that the tablet should be taken with or immediately after meals. Taking the medicine with food, as specified on the label, is suggested to help reduce the risk of stomach irritation.


Q: Can Dolofen Plus affect my sleep cycle?

Official drug labels list potential nervous system side effects. Changes to sleep patterns, such as insomnia (difficulty sleeping), are recognized potential side effects listed in the product information.


Q: Is Dolofen Plus safe for people over the age of 65?

Regulatory documents emphasize that use in older adults requires caution and often a reduced dosage. This is due to an increased risk of serious gastrointestinal or kidney-related side effects in this population.


Q: What is the recommended age range for taking Dolofen Plus?

According to regulatory documents, use of the Diclofenac component is generally not recommended or is contraindicated for children younger than 14 or 15 years old. Eligibility for this medicine is typically limited to adults.


Q: Can I drive or operate machinery after taking Dolofen Plus?

Official warnings state that the medicine may impair the ability to drive or operate machinery if side effects such as dizziness, drowsiness, or visual disturbances occur. Caution is advised.


Q: Is headache a possible side effect of taking Dolofen Plus?

Yes, headache is listed as a possible adverse effect in regulatory safety data. This means it is a recognized effect that may occur while taking the medicine.


Q: Are there any long-term side effects associated with taking Dolofen Plus regularly?

Regulatory warnings indicate that the risk of serious adverse events (such as those affecting the heart, blood vessels, and kidneys) may increase with higher doses and longer durations of treatment. For this reason, regulatory guidance emphasizes using the medicine for the shortest duration necessary.


Q: Is there a maximum amount of days one should continuously take Dolofen Plus?

Regulatory documents emphasize that treatment should be for the shortest duration possible to manage symptoms. If treatment extends past approximately four weeks, product labels indicate the need for the medicine should be re-evaluated by a healthcare professional.


Q: What are the signs that Dolofen Plus might be interacting negatively with another drug?

Regulatory warnings about drug interactions often relate to potentially serious outcomes affecting major body systems, such as the digestive or circulatory systems. Patients are advised to be aware of changes in their health status while taking the medication.


Q: Why do some people say Dolofen Plus is hard on the liver or kidneys?

The drug is processed by the liver and excreted by the kidneys. Regulatory warnings confirm that high doses or long-term use can increase the risk of damage to the liver (due to the Paracetamol component) and the kidneys (due to the Diclofenac component). This necessitates caution for these organs.


Q: What is the risk of allergic reaction to Dolofen Plus?

Official safety data lists severe allergic reactions, such as anaphylaxis (a severe, life-threatening reaction), skin rashes, and hives, as possible adverse effects. A known allergy to the medicine or other similar drugs, such as aspirin, is an official contraindication for use.


Q: Can Dolofen Plus be crushed or split for easier swallowing?

No. Official administration instructions state that the tablets must be swallowed whole with liquid. The product label specifies that the tablets are not to be crushed, broken, or chewed.


Q: Can I use Dolofen Plus for a fever?

Yes, according to some regulatory indications, the medicine is used for the symptomatic treatment of pain and inflammation, and it can also be used to address fevers and symptoms accompanying a rise in body temperature (febrile states).


Q: Is there any research that compares Dolofen Plus to a placebo for pain relief?

Clinical trials and official information indicate that the fixed-dose combination has provided effective pain relief when compared to a placebo (an inactive substance) for the short-term management of acute pain. This evidence supports its approved use.


Q: Can I take Dolofen Plus if I'm already taking a multivitamin or herbal supplement?

Official guidance mentions the importance of discussing all products being taken with a healthcare professional. This includes prescription, non-prescription, herbal medicines, and dietary supplements, as not all potential interactions are documented.


Q: Why might a person switch from a standard pain reliever to Dolofen Plus?

Official product information highlights that Dolofen Plus is a fixed-dose combination that provides a dual mechanism of action. It targets both peripheral inflammation (Diclofenac) and central pain transmission (Paracetamol), offering a comprehensive approach to pain and swelling management.


Q: Are there any foods or beverages that interact with Dolofen Plus?

Regulatory documents explicitly warn that alcohol should be avoided entirely while taking this medication. Chronic consumption of alcohol significantly increases the risk of liver damage associated with the Paracetamol component.


Q: What should I do if I miss a dose of Dolofen Plus?

Information regarding missed doses is contained in the patient information leaflet, which outlines the appropriate steps to follow based on the timing of your next scheduled dose. Refer to the official leaflet for specific guidance.

How should Dolofen Plus be stored and disposed of?

How to Store and Dispose of Dolofen Plus?

The storage and handling of Dolofen Plus (Diclofenac/Paracetamol tablets) must align strictly with regulatory requirements to maintain product quality and safety.

Required Storage Conditions

Detail Requirement
Temperature Store below 30 C in a cool and dry place.
Protection Protect from direct sunlight, moisture, and heat.
Packaging Keep in the container or pack it came in, tightly closed.
Child Safety Keep out of the sight and reach of children and pets.

Official Disposal Rules

Do not use the medicine after the expiration date printed on the package. Unused or expired Dolofen Plus must be disposed of properly by following instructions on the label, or by utilizing an authorized drug take-back program. Do not flush the tablets down the toilet or pour them down the drain unless specifically instructed by the product labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolofen Plus found in:

A-Z Index: